Inconsistent with our findings, one clinical study examining an Eastern European cohort of genomically undefined colon and rectal cancers found that increased levels of cytoplasmic TGFβ1 and loss of SMAD4 were associated with reduced tumor-infiltrating macrophages. Here, TGFB1 is linked to rectal cancer.